But since we indicated last December that the Zetia® antitrust class action had settled, and only a few insurers / drug compounder individual suits remained, and were remanded, to their home district courts. . . we had stopped watching this boxcar litigation.
But apparently, the USDC Judge in Norfolk has spindled what looks like a February 12, 2024 bankruptcy court notice, from one of the smaller "mini-Sackler" type-entities -- one still fighting its way out, to minimize its payments in the opioid cases here in the states.
Honestly, I cannot imagine what sort of a set of facts, or set of prescription drugs, would have had to coalesce, to dump a now largely vanished, last gen, "expensive placebo" supposed cholesterol management drug franchise. . . into the Sackler matters -- or what that would would look like, but I will let wiser heads instruct me, if this is not just a clerk's filing error.
Onward, grinning. . . .
नमस्ते
No comments:
Post a Comment